Examination of a profile of data already existing on 1,3-butadiene shows adequate knowledge in many areas of toxicology that are conventionally required in hazard identification. However, while much progress has been made in areas of metabolism and pharmacokinetics, further studies would be worthwhile to improve mechanistic understanding such as the examination of alternate metabolic pathways, the generation of interspecies scaling factors, and an assessment of the relevance of various tumor sites. In this respect, data pertaining to repeated and pulse exposures of rodents and primates would be helpful.
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Another important aspect is the need to understand any human health implications of the observed 1,3-butadiene-induction of the murine leukemia virus. In this respect, studies have been pursued that include the comparison of leukemogenesis in congenetic strains, the leukemogenicity of viral isolates in rodent carcinogenicity and human cell culture studies, and the mechanisms of activation of ecotropic proviral sequences.
Molecular epidemiological and toxicological research is ongoing in rodents and primates to evaluate hemoglobin adduct formation as an index of 1,3-butadiene exposure. Challenges of specificity, sensitivity, and simplification of current procedures need to be overcome.
Recent mutagenicity and metabolism data suggest that structurally-related isoprene may have carcinogenic potential. The use of interstrain comparative studies and data in a second species is discussed, as well as proposed metabolism studies.
Review of 1 ,3-Butadiene Toxicity
In discussing future research directions for 1,3-butadiene it is appropriate to briefly review the current status of toxicity information on 1,3-butadiene. Existing animal toxicity data for 1,3-butadiene can be arrayed as a toxicological profile in the format that has been utilized by the Agency for Toxic Substances and Disease Registry for other chemicals (Fig. 1) . From this, it is apparent that adequate data exist for these conventional toxicity fields (acute, chronic etc.) to characterize toxic potential, particularly by the inhalation route. There are data in other fields too. With respect to mutagenicity, until recently 1,3-butadiene per se had only been tested in the Salmonella/Ames assay (1) . Now, in vivo genotoxicity data has been generated by Tice et al. (2) and Cunningham et al (3) . The latter authors show an interesting species difference in the incidence of sister chromatid exchanges and of micronuclei occurring in the bone marrow ofthe mouse but not ofthe rat. Sister chromatid exchange in the peripheral blood of 1,3-butadieneexposed primates is being evaluated. Finally, immunotoxicity has been adequately studied by Thurmond et al. (4) with overall no immunological effect seen.
Possible Research Areas
Three areas for possible research are a) metabolism and pharmacokinetic studies (repeated and pulse exposure in rodents and primates); b) mechanisms of murine leukemogenesis (rodent carcinogenicity and human cell culture studies), c) hemoglobin adduct formation as a means of biological monitoring. Each of these areas is now discussed in turn. in vitro and in vivo. Bond et al. (7) have confirmed and extended these observations by demonstrating that the mutagenic 1,2-epoxy-3-butene and diepoxybutane are present in the blood as metabolites of 1,3-butadiene and that these epoxides have been detected at two to five times greater concentrations in the blood of mice than of rats (8) .
Metabolism and Pharmacokinetic Studies
The species differences and variety of carcinogenic and hematological responses indicated in the rodent carcinogenicity studies of 1,3-butadiene (9,10) cast doubt on the omnipotent role presently attributed to these epoxides and allows for the presence and toxic significance of other metabolites. In addition, observations by Anderson et al. (11) show a lowering of hepatic nonprotein sulfhydryl levels following the IP injection of 1,2-epoxy-3-butene, and suggest that the epoxide had been further metabolized. Glutathione S-transferase may play an important role in a toxification or a detoxification pathway for 1,3-butadiene metabolism in the primate (Fig. 2) . Further comparative species studies of the rate and extent of glutathione conjugation and of epoxide hydrolase activity would be beneficial in that they might supply further reason for the species differences in sensitivity or tissue susceptibility.
One possibility that might explain some of the acute hematological effects seen with 1,3-butadiene is the hypothesis that 1,3-butadiene can be metabolized in the mouse to the homologous 4-carbon dialdehyde, namely butenedial (12) . In a joint collaborative project with Surrey University (UK) and the Robert Wood Johnson Medical School in New Jersey, computer graphics and electronic structure calculations (Tables 1 and 2 ) were used to determine that butenedial is likely to share similar lipophilicity and toxic properties as of the 6-carbon dialdehyde, muconaldehyde. Muconaldehyde has been shown to produce hematotoxicity (13 
Mechanisms of Murine Leukemogenesis
The studies of Irons and coworkers (16, 17) show that the endogenous retrovirus (MuLV) may play a role in 1,3-butadiene-induced T-cell lymphoma. A marked difference was found between the incidence of thymic lymphomaAleukemia in the B6C3F1 mouse (57%) exposed to 1,3-butadiene for 1 year and the incidence in the similarly exposed NIH Swiss mouse (14%), a strain in which the MuLV proviral sequences are incomplete. As a future research direction, Irons has suggested that the (20) and by Del Monte et al. (21) indicate that the metabolism of isoprene may be qualitatively similar to that of 1,3-butadiene in terms of the formation of equivalent mono-and diepoxides. Studies of isoprene in primates are being performed to characterize the metabolic profile in that species following an increasing series of concentrations each of 2 hr duration. Melnick et al. (22) are using an extended 3-month toxicity study (6-month exposure/6-month hold) to determine whether or not isoprene will produce thymic lymphoma/leukemia and other tumors in the B6C3F1 mice, which was the case for 1,3-butadiene under a similar testing regimen. Further metabolism studies in the B6C3F1 mouse are also planned by the National Toxicology Program to compliment the published work in the rat.
The International Institute of Synthetic Rubber Producers (IISRP) is examining the merits of a 1-year interstrain comparative study of isoprene, similar to that conducted by Irons (16) with 1,3-butadiene in the NIH Swiss and B6C3Fj mouse and a two-year study of isoprene in the Sprague-Dawley rat. These studies would provide a comparison to 1,3-butadiene and complement the possible retrovirus research proposal, described previously for 1,3-butadiene. Industrial hygiene data-gathering and a prospective epidemiology study are also being considered for isoprene.
Conclusion
Our understanding of 1,3-butadiene, more so than for many other compounds, has benefitted from the recent burst of research activity on this compound. It is anticipated that future research will lead to a better understanding of species differences in metabolism and tumorigenic response, which in turn should reduce current uncertainties in risk-assessment modeling.
